The latest biotechnology news | Bio News
IMG_7907

BIO 2025: The urgent need to address AMR and cancer

As antimicrobial resistance (AMR) continues to threaten global public health, its impact on ...
Read More
drug patent

BIO expert explains patents at DOJ and FTC listening session

Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive ...
Read More
Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally ...
Read More
404(b) biotechs

Onerous reporting requirements crushing small biotechs, BIO Board member testifies

Even if they aren’t making revenue, small biotechs can face onerous reporting requirements ...
Read More
race and pace

BIO 2025: The innovation race vs. the regulatory pace

We often talk about the exciting jumps in technology and innovation that improve ...
Read More
BIO25_ThursdayMainStage_2

BIO 2025: The world can’t wait – it needs to collaborate

Biotech is a global business, and we’re better for it, said experts at ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

BIO Events

BIO 2025: The urgent need to address AMR and cancer

As antimicrobial resistance (AMR) continues to threaten global public health, its impact on cancer patients is a growing, often overlooked crisis. Patients with cancer are ...
Federal Policy

BIO expert explains patents at DOJ and FTC listening session

Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive market, the top IP expert for the Biotechnology Innovation Organization (BIO) told ...
BIO Events

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
BIO's View

Onerous reporting requirements crushing small biotechs, BIO Board member testifies

Even if they aren’t making revenue, small biotechs can face onerous reporting requirements that cost $1 million or more, cutting into the firms’ ability to ...
BIO Events

BIO 2025: The innovation race vs. the regulatory pace

We often talk about the exciting jumps in technology and innovation that improve and save lives. What is less frequently discussed is how regulation has ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

AGRICULTURE

Climate Change

climate food

Combatting misinformation on biotechnology in food

Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More

Federal Policy

State Policy

BIO 2025: A few highlights from Day 2

George W. Bush, 43rd President of the United States, headlined Tuesday’s mainstage with an exclusive conversation with Biotechnology Innovation Organization ...
Read More

International

Bio's View